➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

PREVACID 24 HR Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Prevacid 24 Hr, and when can generic versions of Prevacid 24 Hr launch?

Prevacid 24 Hr is a drug marketed by Perrigo Pharma Intl and is included in one NDA.

The generic ingredient in PREVACID 24 HR is lansoprazole. There are fifty-six drug master file entries for this compound. Seventy-eight suppliers are listed for this compound. Additional details are available on the lansoprazole profile page.

US ANDA Litigation and Generic Entry Outlook for Prevacid 24 Hr

A generic version of PREVACID 24 HR was approved as lansoprazole by MYLAN PHARMS INC on November 10th, 2009.

  Start Trial

Summary for PREVACID 24 HR
Drug patent expirations by year for PREVACID 24 HR
Recent Clinical Trials for PREVACID 24 HR

Identify potential brand extensions & 505(b)(2) entrants

TakedaPhase 3
Janssen Research & Development, LLCPhase 1
McGill University Health CenterPhase 4

See all PREVACID 24 HR clinical trials

US Patents and Regulatory Information for PREVACID 24 HR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Pharma Intl PREVACID 24 HR lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 022327-001 May 18, 2009 OTC Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.